Looking for something specific?
At 9M India Limited, trust through quality, transparency, performance.
What We Manufacture
Analgesic capsules offer patient preference advantages over tablets for some populations and allow certain formulation approaches (liquid-filled capsules, modified-release pellet capsules) not achievable in tablet form. Our analgesic capsule range:

Why 9M India
Tramadol and Pregabalin are controlled substances (Schedule H1) requiring dedicated documentation, licensed storage and batch-level controlled substance manufacturing records. 9M India holds the necessary licences for Schedule H1 pharmaceutical manufacturing and maintains the additional documentation and security controls required for Tramadol and Pregabalin capsule production.
Disintegration · Dissolution (IR and MR profiles) · Assay by HPLC · Content uniformity · Microbial limits · Chiral purity (Tramadol enantiomers) — all in-house. COA per batch.
Manufacturing Licence · DCGI product approvals · WHO-GMP Certificate · COA · COC · Stability data — pre-prepared and available within 24 hours for tender submission, export registration or contract manufacturing due diligence.
Who We Supply
Government & institutional buyers
Government hospital formularies, pain clinics, CGHS, ESIC — Tramadol, Pregabalin and Gabapentin are standard formulary items across government healthcare facilities.
Private label & contract manufacturing partners
Domestic pharma brands manufacturing analgesic capsules through 9M India — Pregabalin capsules in particular are one of the fastest-growing prescription categories in India.
International export buyers
Middle Eastern and South-East Asian buyers — neuropathic pain drug demand is rising consistently across export markets as diabetic neuropathy becomes more prevalent.
Share your molecule, formulation, pack size and target market. We confirm capability, documentation and lead times within 24 hours.
WHO-GMP
Certified
In-House QC
Contract &
3PM Available
DCGI
Approved
Therapeutic Categories
Our capsule portfolio covers the therapeutic areas with the highest demand across domestic distribution, institutional supply and international export markets.